The effect of Q10 on breast cancer treatment
Not Applicable
- Conditions
- Breast cancer.Malignant neoplasm of breastC44.5,C50.
- Registration Number
- IRCT2015042021874N1
- Lead Sponsor
- Vice Chancellor for research of Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Inclusion criteria : diagnosed with positive estrogen receptor breast cancer by a physician; chemotherapy and radiation therapy, and a history of taking tamoxifen for at least a year; Not taking Q10 supplement and other antioxidants such as vitamin E; Willingness to comply with all interventions and follow-up procedures; Non-pregnant and non-lactating; Having no uncontrolled diseases such as diabetes and thyroid; Not taking non-prescription drugs, corticosteroids, statins
Exclusion criteria : metastasis; partial or total mastectomy and not having any of the above entry criteria
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quten serum levels. Timepoint: Before intervention. Method of measurement: Pg/ml using biochemical kits.;Interluekin 6 serum levels. Timepoint: Before and after intervention. Method of measurement: Pg/ml using biochemical kits.;Interluekin 8 serum levels. Timepoint: Before and after intervention. Method of measurement: Pg/ml using biochemical kits.;VEGF serum levels. Timepoint: Before and after intervention. Method of measurement: Pg/ml using biochemical kits.;Quality of life. Timepoint: Before and after intervention. Method of measurement: Breast cancer Quality of Life Questionnaire.
- Secondary Outcome Measures
Name Time Method Weight. Timepoint: Before and after intervention. Method of measurement: Scale.;Dietary intake. Timepoint: Before and after intervention. Method of measurement: Three-day record.